| Description |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Asian Continental |
Diclofenac Sodium 75mg |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Sami Pharmaceutical |
Diclofenac Sodium 75mg |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Sami Pharmaceutical |
Diclofenac Sodium 100mg |
| Product Type |
Product Size |
| Tablets |
15'S |
| Product Company |
| Searle Pharma |
Paracetamol and Orphenadrine Citrate |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
AJM Pharmaceuticals |
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Aqvida |
|
| Content | Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).Label NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. | Diclofenac is indicated for use in the treatment of pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma. | This medicine is used in the management of muscular and skeletal disorder pain, rheumatoid arthritis, osteoarthrosis, ankylosing spondylitis (arthritis affecting joints of spine), acute gout (complex form of arthritis with extreme pain and swelling of joints) and chronic juvenile arthritis (arthritis in children). | Nuberol Forte® (Paracetamol 650 mg + Orphenadrine 50 mg) for the symptomatic management of the painful musculoskeletal disorders one tablet three times a day or as per physician discretion or as per severity of pain and treatment duration is 7-10 days. | Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. | Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. |
Reviews
There are no reviews yet.